Wiloxin for wilsons pak ltd

505 views
443 views

Published on

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
505
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Wiloxin for wilsons pak ltd

  1. 2. COMMITEE MEMBERS <ul><li>THAWBAN BAIG </li></ul><ul><li>MARKETING MANAGER </li></ul><ul><li>WAQAR HANIF </li></ul><ul><li>MARKET RESEARCHER </li></ul><ul><li>AYSHA SHAHID </li></ul><ul><li>CONSUMER RESEARCHER </li></ul><ul><li>UMER AHMED </li></ul><ul><li>LEGAL ADVISOR </li></ul>
  2. 3. WILOXIN, A REVOLUTIONARY MEDICINE
  3. 4. WELCOME TO THE MARKETING DEPARTMENT OF WILSONS PHARMACEUTICALS PAKISTAN LTD .
  4. 5. TABLE OF CONTENTS <ul><li>INTRODUCTION </li></ul><ul><li>MARKET FEASIBILITY </li></ul><ul><li>CONSUMER DEMAND </li></ul><ul><li>GOVERNMENT POLICIES </li></ul><ul><li>ADVERTISEMENT PLAN </li></ul>
  5. 6. INTRODUCTION <ul><li>PROBLEM </li></ul><ul><li>PERCENTAGE OF PATIENTS </li></ul><ul><li>WHERE WILOXIN STANDS…? </li></ul>
  6. 7. INTRODUCTION <ul><li>COMPOSITION OF WILOXIN (CLARITHROMYCIN + OFLAOXACIN) </li></ul><ul><li>USAGE </li></ul>
  7. 8. WARNING WILOXIN IS &quot;PREGNANCY CATEGORY C&quot; MEDICATIONS, INDICATING THAT NO STUDIES HAVE BEEN CONDUCTED TO ASSESS THE SAFETY OF THIS DRUG FOR PREGNANT WOMEN. NO SAFETY PROBLEMS HAVE BEEN IDENTIFIED FOR USE OF THIS TYPE OF MEDICATIONS FOR PREGNANT WOMEN HOWEVER, BECAUSE OF THE UNKNOWN EFFECTS OF THIS DRUG ON PREGNANT WOMEN AND INFANTS WHO WERE EXPOSED BEFORE BIRTH, THESE DRUGS SHOULD BE USED DURING PREGNANCY ONLY IF THE POTENTIAL BENEFIT JUSTIFIES THE POTENTIAL RISK TO THE UNBORN CHILD.
  8. 9. MARKET FEASIBILITY ANALYSES
  9. 10. MARKET FEASIBILITY ANALYSIS <ul><li>SCOPE OF PRODUCT </li></ul><ul><li>COST </li></ul><ul><li>COMMON ILLNESS </li></ul><ul><li>WIDE MARKET </li></ul>
  10. 11. MARKET FEASIBILITY ANALYSIS <ul><li>MARKET ANALYSIS </li></ul>S# BRAND NAME PACK SIZE COMPANY NAME PRICE (RS) 1 WILOXIN 250 MG TAB 1X10'S WILSON PHARMA 99 2 KLARICIDN 250 MG TAB 1X10'S ABBOT 296 3 CLARION 250 MG TAB 1X10'S FEROZSONS 186 4 CLARITEK 250 MG TAB 1X10'S GETZ 323 1 WILOXIN 500 MG TAB 1X10'S WILSON PHARMA 310 2 KLARICIDN 500 MG TAB 1X10'S ABBOT 648 3 CLARION 500 MG TAB 1X10'S FEROZSONS 432 4 CLARITEK 500 MG TAB 1X10'S GETZ 571
  11. 12. MARKET FEASIBILITY ANALYSIS <ul><li>TARGET MARKETS </li></ul><ul><ul><li>RAWALPINDI AND ISLAMABAD </li></ul></ul><ul><ul><li>HIGH POLLEN COUNT </li></ul></ul><ul><ul><li>ALL AGE GROUP </li></ul></ul><ul><li>MARKET POTENTIAL </li></ul><ul><ul><li>TOTAL POULATION </li></ul></ul><ul><ul><li>POLLEN ENERGY PATIENT </li></ul></ul><ul><ul><li>HUGE MARKET </li></ul></ul>
  12. 13. CONSUMER DEMAND AND PROFIT
  13. 14. CONSUMER DEMAND AND PROFIT <ul><li>POPULATION OF RAWALPINDI AND ISLAMABAD (4.41 MILLION AND 1.74 MILLION) </li></ul><ul><li>TARGET AREA </li></ul><ul><li>GOLDEN PERIOD OF SALES </li></ul>
  14. 15. CONSUMER DEMAND AND PROFIT <ul><li>ALLERGY AND INFLUENZA PATIENTS </li></ul><ul><li>ESTIMATED CONSUMER DEMAND IN RAWALPINDI </li></ul><ul><li>ESTIMATED CONSUMER DEMAND IN ISLAMABAD </li></ul><ul><li>ESTIMATED PROFIT </li></ul>
  15. 16. GOVERNMENT POLICIES AND OUR PLAN
  16. 17. GOVERNMENT POLICIES <ul><li>TO ENSURE AVAILABILITY OF SAFE, EFFECTIVE AND QUALITY PRODUCT </li></ul><ul><li>THE DRUG ACT 1976 </li></ul><ul><li>SYSTEM OF LICENCING </li></ul><ul><li>TQM </li></ul>
  17. 18. GOVERNMENT POLICIES <ul><li>CHEAP PRODUCT </li></ul><ul><li>LOCAL EQUIPMENT </li></ul><ul><li>TAX FREE EQUIPMENT </li></ul><ul><li>PRICE BASED UPON QUALITY </li></ul>
  18. 19. GOVERNMENT POLICIES <ul><li>RESTRICTION ON MIS-USING </li></ul><ul><li>PROMOTE CONCEPT OF RATIONAL USE OF MEDICINE </li></ul><ul><li>SALE WITHOUT DOCTOR’S PERSCRIPTION IS RESTRICTED </li></ul><ul><li>LEGALLY CANCELLATION OF LICENCE </li></ul>
  19. 20. GOVERNMENT POLICIES <ul><li>AVAILABILITY OF DRUGS </li></ul><ul><li>WILSONS MEDICINE STOCK STORES </li></ul><ul><li>WILSONS SALE POINTS </li></ul><ul><li>SUPPLY ISSUE </li></ul>
  20. 21. GOVERNMENT POLICIES <ul><li>AVAILABILITY OF INGREDIENTS </li></ul><ul><li>PURCHASE OF INGREDIENTS IN BULK </li></ul><ul><li>FREE FROM HURDLES </li></ul><ul><li>MAINTAIN THE INGREDIENT QUALITY </li></ul>
  21. 22. GOVERNMENT POLICIES <ul><li>AVOIDING MANUFACTURING SUBSTANDARD MEDICINES </li></ul><ul><li>TESTING OF INGREDIENTS </li></ul><ul><li>RIGHT OF HEALTH MINISTRY </li></ul><ul><li>WILSON HAS LATEST LABORATORIES </li></ul>
  22. 23. ADVERTISEMENT PLAN
  23. 24. ADVERTISEMENT PLAN <ul><li>MEDIUMS USED FOR ADVERTISEMENT </li></ul><ul><ul><li>TELEVISION </li></ul></ul><ul><ul><li>NEWSPAPERS </li></ul></ul><ul><ul><li>RADIO </li></ul></ul><ul><ul><li>SIGN BOARDS </li></ul></ul><ul><ul><li>BROCHERS </li></ul></ul><ul><ul><li>WALLPAPERS </li></ul></ul><ul><ul><li>NOTE PADS, PENS AND GIFTS </li></ul></ul>
  24. 25. ADVERTISEMENT PLAN <ul><li>VIDEO </li></ul>

×